Since PLD2 regulates nuclear ERK activity in several cancer cell lines92 it is not surprising that proliferation of prostate cell lines and patient-derived PCa cells is effectively inhibited by JWJ (Fig. 5a, b). Here, PLD2 is linked to medical procedure.